AHRQ reviews off label uses in cancer
This is a discussion on AHRQ reviews off label uses in cancer within the Comparative Effectiveness Updates forum, part of the Industry News and Updates category; In a recent news article , the Agency for Healthcare Research and Quality (AHRQ) summarized recent research on unapproved indications for ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-03-2010, 11:08 AM
|
||||
|
||||
AHRQ reviews off label uses in cancer
In a recent news article, the Agency for Healthcare Research and Quality (AHRQ) summarized recent research on unapproved indications for eight mAbs and kinase inhibitors.
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| AHRQ Issues Annual Quality and Disparities Reports | industry_news | Other Clinical Pharmacy News | 0 | 04-16-2010 03:10 PM |
| Updating Comparative Effectiveness Reviews | industry_news | Comparative Effectiveness Updates | 0 | 10-27-2009 09:14 AM |
| AHRQ: Providing 100% of Patients With Ideal Standard of Care Will Eliminate Disparities | industry_news | Other Clinical Pharmacy News | 0 | 09-16-2009 03:48 PM |
| Compendia Guiding Off-Label Use of Cancer Drugs Inadequate | industry_news | Other Clinical Pharmacy News | 0 | 02-21-2009 11:13 AM |
| Value of comparative effectiveness reviews | diana.papshev | Managed Care Pharmacy Administrative Issues | 4 | 07-31-2008 03:39 PM |
© 2008 DrugManagementForum™ powered by |
 |